Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes.

Thumbnail
URI
http://hdl.handle.net/11287/618037
Author
Myngheer, N.
Allegaert, K.
Hattersley, Andrew T.
McDonald, Timothy J.
Kramer, H.
Ashcroft, F. M.
Verhaeghe, J.
Mathieu, C.
Casteels, K.
Date
2014-12
Journal
Diabetes care
Type
Journal Article
Case Report
Research Support, Non-U.S. Gov't
Publisher
American Diabetes Association
DOI
10.2337/dc14-1247
Rights
Archived with thanks to Diabetes Care
Metadata
Show full item record
Abstract
Sulfonylureas (SUs) are effective at controlling glycemia in permanent neonatal diabetes mellitus (PNDM) caused by KCNJ11 (Kir6.2) mutations.
Citation
Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes. 2014, 37 (12):3333-5 Diabetes Care
Publisher URL
http://care.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=25231897
Collections